Skip to content

Clinical trials

Phase 2/3 Liver Neoplasms trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Liver Neoplasms Phase: Phase 2/3 Country / region: China Clear all

8 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20082
20111
20131
20221
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status3
Completed2
Recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
RenJi Hospital2
Eastern Hepatobiliary Surgery Hospital1
Fudan University1
Qingdao Central Hospital1
Second Affiliated Hospital of Guangzhou Medical University1
Sun Yat-sen University1
Tularik1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Liver Neoplasms8
Carcinoma, Hepatocellular4
Lung Neoplasms2
Neoplasms2
Adenocarcinoma1
Carcinoma, Transitional Cell1
Cholangiocarcinoma1
Digestive System Diseases1
Digestive System Neoplasms1
Endometrial Neoplasms1

Trials

Showing 1 to 8 of 8. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.